Specialty chemicals company Lanxess is expanding its range of membrane elements for reverse osmosis (RO).
Leverkusen/Germany — According to the manufacturer, the new Lewabrane RO ULP line has three product grades available immediately for water treatment, adding that they display higher water permeability than the standard elements, while offering the similar high level of rejection of critical substances. The operating pressure required in the pressure vessel is 40 % lower, which reduces operating costs, the company claims. The new membranes are suitable for removing trace elements from wastewater and drinking water.
“The new ULP products are recommended for applications in which a high flow rate, moderate salt rejection and low power consumption are the primary design parameters. Fields of application therefore are the cost-efficient filtration of drinking water and high-tech wastewater treatment,” says Alexander Scheffler, director membrane business in the LANXESS Liquid Purification Technologies business unit (LPT). “Our customers are so impressed with the performance profile that we already have received numerous pre-orders,” he adds.
Eliminating Trace Elements
Synthetic organic substances, known as trace elements, can be found in bodies of water in concentrations of a few nanograms to a maximum of a few micrograms per liter. Originating for instance from drugs, household chemicals, industrial chemicals, cosmetic products and crop protection agents, they are introduced into the water system by household and industrial wastewater.
The product designation “ULP” stands for “Ultra Low Pressure,” because of their ability to remove such organic compounds at low operating pressures. “Drinking water systems process tremendous volumes of surface water often on a daily basis. Therefore, to minimize investment costs, it is desirable to have a membrane that displays high water permeability and thus a high flow rate, like those in our Lewabrane RO ULP line,” explains Scheffler.
To reduce the formation of organic deposits — i.e. typical biofouling — in wastewater, the ULP membrane uniquely has the most hydrophilic surface of all the Lewabrane product grades. Due to this hydrophilic behavior, a thin, protective film of water forms on the membrane surface, which reduces the adsorption of organic substances.
The ASD feed spacers, which are inserted in the membrane elements to create space between their surfaces for flowing water, also reduce fouling. They have an alternating strand design (ASD), comprising filaments of different thickness, which cause uniform overflow and thus counteract biofouling. According to the company, this lowers operating costs because fewer cleaning chemicals are required and the interval between cleanings can be extended.
The research project on “Modular Treatment and Monitoring in Wastewater Recycling (Multi-ReUse)” was launched in 2016 with funding from the German Federal Ministry of Education and Research (BMBF). This project aims to develop and improve processes for the economical use of wastewater. Against this backdrop, the Oldenburgisch-Ostfriesische Wasserverband (OOWV Water Management Association) joined forces with research partners — IWW Zentrum Wasser and the Biofilm Center at Duisburg-Essen University (UDE) — and equipment companies inge, IAB Ionenaustauscher (a wholly owned Lanxess subsidiary) and De.Encon to develop flexible processes for producing defined water qualities and volumes. To achieve its goals, the consortium is using innovative processing combinations and new developments in the field of membrane technology. At the same time, fast and reliable methods are being developed for process control and for monitoring the quality of hygiene-relevant parameters.
The results are being implemented at the Nordenham water treatment plant in Lower Saxony in collaboration with the OOWV. This pilot facility is due to go into operation in July 2017. It incorporates membrane elements from Lanxess, including the new ULP products. “We are studying the fouling and rejection behavior of our membrane elements in long-term practical trials,” explains Scheffler.